The Effect of Glutamatergic Modulation on Cocaine Self-administration
NCT02596022
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Cocaine Dependence
Interventions
DRUG:
CI-581a
DRUG:
CI-581b
Sponsor
New York State Psychiatric Institute